Showing results (31-40 of 92) with videos related to
Sort By:
Pageof 10
Journal of Analytical Toxicology|October 1, 1995
Identification and quantitation of ibogaine and an o-demethylated metabolite in brain and biological fluids using gas chromatography-mass spectrometryW L Hearn, J Pablo, G W Hime, et al.The Journal of Comparative Neurology|April 15, 1992
Differential cholinergic innervation within functional subdivisions of the human cerebral cortex: a choline acetyltransferase studyM M Mesulam, L B Hersh, D C Mash, et al.Molecular Pharmacology|December 1, 1994
Selective labeling and localization of the M4 (m4) muscarinic receptor subtypeG Ferrari-Dileo, M Waelbroeck, D C Mash, et al.Brain Research|April 1, 1985
Circadian variations in radioligand binding to muscarine receptors in rat brain dependent upon endogenous agonist occupationD C Mash, D D Flynn, L Kalinoski, et al.Journal of Neurochemistry|February 1, 1994
Visualizing dopamine and serotonin transporters in the human brain with the potent cocaine analogue [125I]RTI-55: in vitro binding and autoradiographic characterizationJ K Staley, M Basile, D D Flynn, et al.Journal of Medicinal Chemistry|November 7, 1998
Modified ibogaine fragments: synthesis and preliminary pharmacological characterization of 3-ethyl-5-phenyl-1,2,3,4,5, 6-hexahydroazepino[4,5-b]benzothiophenesS M Efange, D C Mash, A B Khare, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 24, 1999
Noribogaine generalization to the ibogaine stimulus: correlation with noribogaine concentration in rat brainC Zubaran, M Shoaib, I P Stolerman, et al.Neuroscience Letters|August 15, 1986
Localization of nerve growth factor receptors in cholinergic neurons of the human basal forebrainF Hefti, J Hartikka, A Salvatierra, et al.Pharmacology, Biochemistry, and Behavior|June 1, 1991
Cocaethylene is more potent than cocaine in mediating lethalityW L Hearn, S Rose, J Wagner, et al.Life Sciences|January 1, 1995
Differential alterations in muscarinic receptor subtypes in Alzheimer's disease: implications for cholinergic-based therapiesD D Flynn, G Ferrari-DiLeo, A I Levey, et al.Pageof 10